Table 2.

The patients’ characteristics.

Characteristic	A-A	Caucasian	P
Number of patients	117	544
Median (range)
Age, years	63.0 (44–81)	64.5 (30–87)	0.003
Pre-biopsy PSA level, ng/mL	7.1 (0.3–61.6)	6.9 (0.2–51.2)	0.274
Estimated prostate volume, mL	52.9 (17.6–178.3)	51.9 (14.5–247.6)	0.585
Number of lesions detected on mpMRI/patient	2.0 (1–5)	2.0 (1–5)	0.878
N (%)
Clinical T stage, cT1/cT2	106 (90.6)/8 (6.8)	492 (90.4)/36 (6.6)	0.973
Reason for biopsy
Rising PSA – previous negative biopsy	49 (41.9)	238 (43.8)	0.134
Active surveillance – prostate cancer	30 (25.6)	155 (28.5)
Elevated PSA – biopsy naїve	13 (11.1)	78 (14.3)
Atypical cells on previous biopsy	24 (20.5)	64 (11.8)
Other	1 (0.9)	9 (1.7)